A Novel Approach for Self-Care in Pregnant Women With Hypothyroidism: Mobile-Based Development and Insights
- PMID: 40535519
- PMCID: PMC12174654
- DOI: 10.1002/hsr2.70679
A Novel Approach for Self-Care in Pregnant Women With Hypothyroidism: Mobile-Based Development and Insights
Abstract
Background and aim: Hypothyroidism affects 2-3% of pregnant women. This study aims to develop a mobile self-care program to enhance self-management and health outcomes for these women.
Methods: The present study is a developmental and applied research that was conducted in three stages at the Yas Hospital's Women's Clinic and Pregnancy Care Center affiliated with Tehran University of Medical Sciences in 2023. In the first stage, the informative elements of the program were determined through a review of previous studies and a survey of 20 obstetricians and endocrinologists. In the second stage, a prototype of the mobile-based application was developed. In the third stage, the designed application was evaluated by 10 medical informatics and technology specialists using Nielsen's standard usability questionnaire. The questionnaire results were analyzed using descriptive statistics and SPSS 16 software.
Results: In the first stage, 58 informative elements and 9 vital capabilities were identified for the self-care application, and then the application was designed using Java programming language in two sections: user registration and main page, which includes medical information, medical records, tests, and reminders (doctor's appointments, medication and supplement intake, and laboratory tests). Overall, the usability test results of the self-care application by experts showed that the usability of this application for pregnant women with hypothyroidism was evaluated at an acceptable level.
Conclusions: Mobile applications enhance awareness, improve health, and provide essential tools for disease management in pregnant women, reducing complications and benefiting the health of mothers and newborns.
Keywords: hypothyroidism; mobile application; pregnant women; self‐care; smartphone.
© 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.J Parkinsons Dis. 2025 Jun;15(4):789-804. doi: 10.1177/1877718X251330993. Epub 2025 Apr 29. J Parkinsons Dis. 2025. PMID: 40302366
-
Quality Assessment of Web-Based Information Related to Diet During Pregnancy in Pregnant Women: Cross-Sectional Descriptive Study.JMIR Form Res. 2025 Jun 3;9:e64630. doi: 10.2196/64630. JMIR Form Res. 2025. PMID: 40460424 Free PMC article.
-
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887. Elife. 2025. PMID: 40407808 Free PMC article.
-
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3. Cochrane Database Syst Rev. 2019. PMID: 31745984 Free PMC article.
-
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression.Br J Dermatol. 2024 Jun 20;191(1):24-35. doi: 10.1093/bjd/ljae011. Br J Dermatol. 2024. PMID: 38197404
References
-
- Wiśniewski K., Bełej M., and Wojtkiewicz J., “Associations Between Serum Levels of Thyroid Stimulating Hormone (TSH), Free Thyroxine (fT4), Free Triiodothyronine (fT3) and Clinical Symptoms in Patients Diagnosed With Hashimoto's Thyroiditis,” Polish Annals of Medicine 27, no. 2 (2020): 96, 10.29089/2020.20.00123. - DOI
-
- Gottwald‐Hostalek U. and Kahaly G. J., “Optimizing Levothyroxine Treatment for Subclinical Hypothyroidism During Pregnancy,” Current Medical Research and Opinion 40, no. 1 (2024): 43–49. - PubMed
LinkOut - more resources
Full Text Sources